SCOPUS 정보 검색 플랫폼

Health Economics

Volumn 21, Issue 5, 2012, Pages 496-513

New drugs and the growth of health expenditure: Evidence from diabetic patients in Taiwan

(2) Liu, Y Ming a Hsieh, Chee Ruey b

a NATIONAL CHENG KUNG UNIVERSITY (Taiwan)

b INSTITUTE OF ECONOMICS (Taiwan)

Author keywords

Health expenditure; New drugs; Treatment expansion; Treatment substitution

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TAIWAN;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DRUG COSTS; DRUG SUBSTITUTION; FEMALE; HEALTH EXPENDITURES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; REGRESSION ANALYSIS; TAIWAN; THIAZOLIDINEDIONES;

EID: 84855983919 PISSN: 10579230 EISSN: 10991050 Source Type: Journal
DOI: 10.1002/hec.1724 Document Type: Article

Times cited : (9)

References (18)

1
- 66149131064
- Diabetes in Asia: Epidemiology, risk factors, and pathophysiology
- Chan JCN, Malik V, Jia W et al. 2009. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Journal of the American Medical Association 301: 2129-2140.
- (2009) Journal of the American Medical Association , vol.301 , pp. 2129-2140
- Chan, J.C.N.¹ Malik, V.² Jia, W.³

2
- 0023092594
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
- DOI 10.1016/0021-9681(87)90171-8
- Charlson ME, Pompei P, Ales KL, Mackenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40: 373-383. (Pubitemid 17055592)
- (1987) Journal of Chronic Diseases , vol.40 , Issue.5 , pp. 373-383
- Charlson, M.E.¹ Pompei, P.² Ales, K.A.³ MacKenzie, C.R.⁴

3
- 0141537992
- National Health Insurance and precautionary saving: Evidence from Taiwan
- DOI 10.1016/S0047-2727(01)00205-5, PII S0047272701002055
- Chou SY, Liu JT, Hammitt JK. 2003. National health insurance and precautionary saving: evidence from Taiwan. Journal of Public Economics 87: 1873-1894. (Pubitemid 37170198)
- (2003) Journal of Public Economics , vol.87 , Issue.9-10 , pp. 1873-1894
- Chou, S.-Y.¹ Liu, J.-T.² Hammitt, J.K.³

4
- 0035134407
- Health insurance and female labor supply in Taiwan
- DOI 10.1016/S0167-6296(00)00075-8, PII S0167629600000758
- Chou YJ, Staiger D. 2001. Health insurance and female labor supply in Taiwan. Journal of Health Economics 20: 187-211. (Pubitemid 32141104)
- (2001) Journal of Health Economics , vol.20 , Issue.2 , pp. 187-211
- Chou, Y.J.¹ Staiger, D.²

5
- 77951719204
- The effect of newer drugs on health spending: Do they really increase the costs?
- Civan A, Köksal B. 2010. The effect of newer drugs on health spending: do they really increase the costs? Health Economics 19: 581-595.
- (2010) Health Economics , vol.19 , pp. 581-595
- Civan, A.¹ Köksal, B.²

6
- 0344646776
- Is technological change in medicine worth it?
- Cutler DM, McClellan M. 2001. Is technological change in medicine worth it? Health Affairs 20: 11-29. (Pubitemid 33710338)
- (2001) Health Affairs , vol.20 , Issue.5 , pp. 11-29
- Cutler, D.M.¹ McClellan, M.²

7
- 0038460622
- Thiazolidinediones in type 2 diabetes mellitus: Current clinical evidence
- DOI 10.2165/00003495-200363130-00004
- Diamant M, Heine RJ. 2003. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs 63: 1373-1405. (Pubitemid 36776093)
- (2003) Drugs , vol.63 , Issue.13 , pp. 1373-1405
- Diamant, M.¹ Heine, R.J.²

8
- 26244453309
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomised controlled trial
- DOI 10.1016/S0140-6736(05)67528-9, PII S0140673605675289
- Dormandy JA, Charbonnel B, Eckland DJA et al. 2005. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (prospective pioglitazone clinical trial in macrovascular events): a randomized controlled trial. Lancet 366: 1279-1289. (Pubitemid 41416583)
- (2005) Lancet , vol.366 , Issue.9493 , pp. 1279-1289
- Dormandy, J.A.¹ Charbonnel, B.² Eckland, D.J.³ Erdmann, E.⁴ Massi-Benedetti, M.⁵ Moules, I.K.⁶ Skene, A.M.⁷ Tan, M.H.⁸ Lefebvre, P.J.⁹ Murray, G.D.¹⁰ Standl, E.¹¹ Wilcox, R.G.¹² Wilhelmsen, L.¹³ Betteridge, J.¹⁴ Birkeland, K.¹⁵ Golay, A.¹⁶ Heine, R.J.¹⁷ Koranyi, L.¹⁸ Laakso, M.¹⁹ Mokan, M.²⁰ more..

9
- 11144262726
- Do new prescription drugs pay for themselves? The case of second-generation antipsychotics
- DOI 10.1016/j.jhealeco.2004.08.001, PII S016762960400102X
- Duggan M. 2005. Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. Journal of Health Economics 24: 1-31. (Pubitemid 40023070)
- (2005) Journal of Health Economics , vol.24 , Issue.1 , pp. 1-31
- Duggan, M.¹

10
- 41549105383
- Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: Is it cost effective?
- DOI 10.1111/j.1524-4733.2007.00235.x
- Hsieh CR, Sloan FA. 2008. Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: is it cost effective? Value in Health 11: 334-344. (Pubitemid 351473612)
- (2008) Value in Health , vol.11 , Issue.2 , pp. 334-344
- Hsieh, C.-R.¹ Sloan, F.A.²

11
- 0442277183
- Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS
- Lichtenberg F. 2001. Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS. Health Affairs 20: 241-251. (Pubitemid 33710357)
- (2001) Health Affairs , vol.20 , Issue.5 , pp. 241-251
- Lichtenberg, F.R.¹

12
- 84859421814
- Mimeo
- Lin CC, Lai MS, Hsieh CR. 2009. Therapeutic and generic substitution in the pharmaceutical market: the role of price. Mimeo.
- (2009) Therapeutic and Generic Substitution in the Pharmaceutical Market: The Role of Price
- Lin, C.C.¹ Lai, M.S.² Hsieh, C.R.³

13
- 0034802271
- Direct costs-of-illness of patients with diabetes mellitus in Taiwan
- PII S0168822701003084
- Lin T, Chou P, Lai MS, Tsai ST, Tai TY. 2001. Direct cost-of-illness of patients with diabetes mellitus in Taiwan. Diabetes Research and Clinical Practice 54: S43-S46. (Pubitemid 32907246)
- (2001) Diabetes Research and Clinical Practice , vol.54 , Issue.SUPPL. 1
- Lin, T.¹ Chou, P.² Lai, M.-S.³ Tsai, S.-T.⁴ Tai, T.-Y.⁵

14
- 34548590934
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials
- DOI 10.1001/jama.298.10.1180
- Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. 2007. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. Journal of American Medical Association 298: 1180-1188. (Pubitemid 47403104)
- (2007) Journal of the American Medical Association , vol.298 , Issue.10 , pp. 1180-1188
- Lincoff, A.M.¹ Wolski, K.² Nicholls, S.J.³ Nissen, S.E.⁴

15
- 62049084257
- Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan
- Liu YM, Kao Yang YH, Hsieh CR. 2009. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. Journal of Health Economics 28: 341-349.
- (2009) Journal of Health Economics , vol.28 , pp. 341-349
- Liu, Y.M.¹ Kao Yang, Y.H.² Hsieh, C.R.³

16
- 79953117559
- The determinants of the adoption of pharmaceutical innovation: Evidence from Taiwan
- DOI: 10.1016/j.socscimed.2010.12.027
- Liu YM, Kao Yang YH, Hsieh CR. 2011. The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan. Social Science and Medicine, DOI: 10.1016/j.socscimed.2010.12.027.
- (2011) Social Science and Medicine
- Liu, Y.M.¹ Kao Yang, Y.H.² Hsieh, C.R.³

17
- 0026883171
- Medical care costs: How much welfare loss?
- Newhouse JP. 1992. Medical care costs: how much welfare loss? Journal of Economic Perspectives 6: 3-21.
- (1992) Journal of Economic Perspectives , vol.6 , pp. 3-21
- Newhouse, J.P.¹

18
- 0034777002
- The demand for consumer health information
- DOI 10.1016/S0167-6296(01)00107-2, PII S0167629601001072
- Wagner TH, Hu TH, Hibbard JH. 2001. The demand for consumer health information. Journal of Health Economics 20: 1059-1075. (Pubitemid 33010788)
- (2001) Journal of Health Economics , vol.20 , Issue.6 , pp. 1059-1075
- Wagner, T.H.¹ Hu, T.-W.² Hibbard, J.H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.